Abstract

Human parasitic nematodes are the causative agents of lymphatic filariasis (elephantiasis) and onchocerciasis (river blindness), diseases that are endemic to more than 80 countries and that consistently rank in the top ten for the highest number of years lived with disability. These filarial nematodes have evolved an obligate mutualistic association with an intracellular bacterium, Wolbachia, a symbiont that is essential for the successful development, reproduction, and survival of adult filarial worms. Elimination of the bacteria causes adult worms to die, making Wolbachia a primary target for developing new interventional tools to combat filariases. To further explore Wolbachia as a promising indirect macrofilaricidal drug target, the essential cellular processes that define the symbiotic Wolbachia-host interactions need to be identified. Genomic analyses revealed that while filarial nematodes encode all the enzymes necessary for glycolysis, Wolbachia does not encode the genes for three glycolytic enzymes: hexokinase, 6-phosphofructokinase, and pyruvate kinase. These enzymes are necessary for converting glucose into pyruvate. Wolbachia, however, has the full complement of genes required for gluconeogenesis starting with pyruvate, and for energy metabolism via the tricarboxylic acid cycle. Therefore, we hypothesized that Wolbachia might depend on host glycolysis to maintain a mutualistic association with their parasitic host. We did conditional experiments in vitro that confirmed that glycolysis and its end-product, pyruvate, sustain this symbiotic relationship. Analysis of alternative sources of pyruvate within the worm indicated that the filarial lactate dehydrogenase could also regulate the local intracellular concentration of pyruvate in proximity to Wolbachia and thus help control bacterial growth via molecular interactions with the bacteria. Lastly, we have shown that the parasite’s pyruvate kinase, the enzyme that performs the last step in glycolysis, could be a potential novel anti-filarial drug target. Establishing that glycolysis is an essential component of symbiosis in filarial worms could have a broader impact on research focused on other intracellular bacteria-host interactions where the role of glycolysis in supporting intracellular survival of bacteria has been reported.

Highlights

  • Human parasitic nematodes such as Wuchereria bancrofti, Brugia malayi, B. timori, and Onchocerca volvulus are responsible for lymphatic filariasis (LF, elephantiasis) and onchocerciasis in more than 80 countries

  • In 2016, the global prevalence of LF was between 24.8 to 36.1 million while for onchocerciasis it was 9.5 to 24.2 million. These nematodes have evolved a mutualistic association with an intracellular bacterium, Wolbachia, an obligatory symbiont that is essential for the successful development, reproduction, and survival of adult filarial worms

  • We evaluated the role of glycolysis—a pathway that is incomplete in Wolbachia—in the symbiotic relationship

Read more

Summary

Introduction

Human parasitic nematodes such as Wuchereria bancrofti, Brugia malayi, B. timori, and Onchocerca volvulus are responsible for lymphatic filariasis (LF, elephantiasis) and onchocerciasis (river blindness) in more than 80 countries. Current control measures depend on annual mass drug administration (MDA) programs that are focused on blocking the transmission of infection with the use of drugs that kill microfilariae (albendazole and ivermectin or diethylcarbamazine citrate for LF; and ivermectin only for onchocerciasis). These are not macrofilaricidal, i.e. they are not effective against the adult worms. To accelerate elimination there is a critical need for safe and affordable drugs with macrofilaricidal effects To facilitate these efforts more basic studies that focus on understanding the biology of these parasites at the molecular level are required

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call